The source “Advancements in NMN biotherapy and research updates in the field of digestive system diseases” is a review focusing on Nicotinamide Mononucleotide (NMN), a precursor to NAD+, a vital coenzyme.
It explores over a decade of preclinical research on NMN’s potential in treating age-related diseases, including its impact on various organs and its emerging role in digestive system health.
The article also presents a balanced assessment of NMN’s benefits, acknowledges the limitations of current studies, and highlights challenges for future research, particularly the need for more human clinical trials to confirm safety and efficacy.
